EXECUTIVE ADVISORY BOARD
The CLP Executive Advisory Board (EAB) is integral to the growth and success of the Institute. Founded in 2005, the Board includes business leaders, entrepreneurs, researchers, physicians and tech experts. The EAB provides members with a gateway to the world of transdisciplinary biomedical discovery, innovation and education. Board members contribute their individual strengths to the Institute in the form of business advice and assistance in commercializing innovations, insight into educational programs, feedback on operations, strategic plans, marketing, fundraising, and individual philanthropy.
James Basta
Executive Vice President, General Counsel and Corporate Secretary, Intellia Therapeutics
Adam Bergstein
Founder and Managing Member, Patent Protection Research, Inc.
Brian Bernick
Founder and Chief Scientific Officer, TherapeuticsMD
Michael Boyne, II
Vice President, Product Development and Analytics, Cour Pharmaceuticals
Joel B. Braunstein
Co-Founder, President and CEO, C2N Diagnostics
Michael Brown
CEO, Euronet Worldwide
Andrew Chan
Senior Vice President of Research Biology, Genentech
John Chen
COO, Hilco Global
Stuart Cornew
Managing Director, AnswerMine
Steven Deitcher
President, CEO and Board Member, Radimmune Therapeutics
President and Managing Member, BeSpoke Biotherapeutics
Timothy Krauskopf
CEO, Motiv Power Systems
Patrick Martin
Principal, Martin Investment Management, LLC
Mani Mohindru
CEO, Novasenta
Christopher J. O'Connell
Corporate Director and Advisor
Michael O'Shea
Founder, The O'Shea Firm
Chandler Robinson
CEO, Monopar Therapeutics
Myung K. Shin
Vice President, Head of Early Discovery Translation, Kallyope, Inc.
Ulrich Thienel
CEO, ReAlta Life Sciences
Tracy Ward
Principal, Schwartz Capital Group